FDA Approves Contrave Weight Control Drug
Dr. Jennifer Ashton explains how the new drug works and the possible health risks.
Why Falling Gas Prices Have Further to Go
Morning Money Memo… There’s good news about the cost of energy: It’s getting cheaper. The cost of oil has been falling for weeks on global markets. West Texas crude is now just under $91 a barrel. The International Energy Agency has again cut its oil...
FDA Panel Gives Nod to New Diet Drug Lorqess
SILVER SPRING, Md. -- An FDA advisory committee has voted 18-4, with one abstention, in favor of approving Lorqess as the first new weight-loss drug in more than a decade. The FDA's Endocrinologic and Metabolic Drugs Advisory Committee on Thursday afternoon voted that the benefits of Lorqess
Qnexa Ruling Renews Debate About Its Risks and Benefits
The decision by a federal advisory panel to recommend Qnexa for approval by the U.S. Food and Drug Administration is drawing praise and criticism from obesity and diet experts, reflecting a still-hot debate on the need for additional tools to treat obesity. The 20 to 2 decision recommending
Makers of Obesity Pills Again Try to Win FDA Approval
Companies developing three different weight-loss pills that were rejected by the U.S. Food and Drug Administration still believe they can eventually bring the products to market, though the firms are taking different approaches to winning over the agency. Vivus Inc., which is developing an oral
Diet Drugs: Weighing Risks, Benefits
Mary Williams wanted to lose weight and was ready to do the work. "With a 5" 5' frame, 215 pounds was just too much," Williams said. "I looked like the Nutty Professor." She tried dieting and exercising. She even tried phentermine, a drug approved for short-term weight loss, which helped her lose a
FDA Says No to Weight -Loss Combo Drug
Agency Will Withhold Approval Until Contrave Manufacturer Evaluates Cardiovascular Risks
Year in Review: More Scrutiny of Dietary Supplements
The U.S. Food and Drug Administration has been busy this year issuing statements and recalls regarding dietary supplements discovered to contain undeclared drug ingredients. Studies have shown that some supplements may increase potentially lethal risks to patients and contain varying amounts of
FDA Panel Supports New Diet Pill After Rejecting Two Others
Contrave is the only diet pill to survive FDA scrutiny in 2010, but no decision expected until January.
FDA Panel Endorses Contrave Weight -Loss Drug
Panel of Experts Votes 13-7 That the Benefits of the Pill Outweigh Its Risks